A Form 4 filed on September 11, 2026, discloses that Elliott Robinson, a director at Hinge Health, Inc. (NYSE:HNGE), reported the sale of Class A Common Stock by affiliated Bessemer Venture Partners funds on September 9, 2026.

Key Highlights

  • Reporting person: Elliott Robinson, identified as a Director of Hinge Health, Inc.
  • Shares sold by BVP X: 5,489 shares of Class A Common Stock sold on September 9, 2026.
  • Shares sold by BVP X Inst: 5,848 shares of Class A Common Stock sold on September 9, 2026.
  • Weighted average price: $92.37 per share, with individual transactions ranging from $92.00 to $92.69, according to the filing.
  • Post-transaction ownership: The filing reports 0 shares of Class A Common Stock beneficially owned following the reported transactions.
  • Ownership form: The shares were held indirectly by the reporting person through the Bessemer Funds.

Bessemer Funds Dispose of Hinge Health Class A Shares via Indirect Ownership

According to the filing, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst"), referred to collectively as the "Bessemer Funds," sold a combined 11,337 shares of Class A Common Stock of Hinge Health, Inc. on September 9, 2026. BVP X sold 5,489 shares and BVP X Inst sold 5,848 shares, both at a weighted average price of $92.37. The filing states the transactions occurred at prices ranging from $92.00 to $92.69 across multiple transactions.

The reporting person, Elliott Robinson, is described in the filing as a partner at Bessemer Venture Partners who holds "an indirect, passive economic interest in the shares held by the Bessemer Funds" by virtue of his interest in Deer X & Co. L.P., the general partner of the Bessemer Funds, and certain other indirect limited partnership interests. The transaction code recorded is "S" (a sale), and the ownership form is listed as indirect.

The filing includes a disclaimer stating that Robinson "disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds," and that "this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities." The form was signed by Augie Wilkinson as attorney-in-fact on September 11, 2026.

What Was Disclosed

The filing reports the sale of 11,337 total shares of Hinge Health Class A Common Stock by two Bessemer Venture Partners funds on September 9, 2026, at a weighted average price of $92.37, as disclosed by Director Elliott Robinson through an indirect ownership structure.